Skip to main content

Table 1 Baseline characteristics of study population

From: Inorganic phosphate and the risk of cancer in the Swedish AMORIS study

 

N (%)

 

No cancer (N=365,810)

Cancer (N=31,482)

Age (years) - Mean (SD)

44.00 (14.00)

55.71 (11.93)

Sex

  

Male

193769 (52.97)

16903 (53.69)

Female

172041 (47.03)

14579 (46.31)

SES

  

White Collar

132733 (36.28)

12064 (38.32)

Blue Collar

174385 (47.67)

14009 (44.50)

Not gainfully employed or Missing

58692 (16.04)

5409 (17.18)

Fasting status

  

Fasting

208923 (57.11)

19547 (62.09)

Non-fasting

113613 (31.06)

8153 (25.90)

Missing

43274 (11.83)

3782 (12.01)

Follow-up time (years) - Mean (SD)

13.12 (3.89)

8.39 (4.68)

Pi 1 (mmol/L) Mean (SD)

1.06 (0.17)

1.04 (0.16)

Calcium (mmol/L) Mean (SD)

2.39 (0.10)

2.39 (0.10)

Alkaline phosphatase (mmol/) Mean (SD)

2.64 (0.96)

2.78 (1.02)

Glucose (mmol/L) - Mean (SD)

4.97 (1.29)

5.19 (1.48)

Creatinine (ÎĽmol/L) - Mean (SD)

81.70 (15.22)

83.77 (16.76)

Season

  

Winter

93580 (25.58)

8328 (26.45)

Spring

99572 (27.22)

8747 (27.78)

Summer

55799 (15.25)

4601 (14.61)

Fall

116859 (31.95)

9806 (31.15)

History of diabetes (ICD-7 260)

1905 (0.52)

201 (0.64)

History of lung disease (ICD-7 470–527)

23709 (6.48)

1791 (5.69)

  1. 1 Pi inorganic phosphate.
  2. ICD-7, International Classification of Diseases, seventh revision.